Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sinon Pharmaceutical is the healthcare and pharmaceutical division of the Taiwan-based Sinon Corporation, a diversified industrial group. The company specializes in the development, manufacturing, and marketing of active pharmaceutical ingredients (APIs) and finished dosage forms, with a primary focus on high-quality generic medications. Their product portfolio covers a wide range of therapeutic areas, including cardiovascular, metabolic, central nervous system, and gastrointestinal disorders. In addition to its proprietary product line, Sinon provides comprehensive contract manufacturing (CMO) and development services to international partners, utilizing its PIC/S GMP-certified facilities. The company is strategically positioned to expand its footprint in global markets through rigorous quality control and cost-effective production. Sinon's pharmaceutical operations are integrated with its chemical expertise, allowing for efficient vertical integration in API synthesis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sinon.